Skip to content

HOME
ABOUT US
INVESTORS
PRESS ROOM
DISEASE FOCUS
INNOVATION
CLINICAL STUDIES
CONTACT

HOME
ABOUT US
INVESTORS
PRESS ROOM
DISEASE FOCUS
INNOVATION
CLINICAL STUDIES
CONTACT

Home
Scientific Presentations
The Michael J. Fox Foundation for Parkinson’s Research: Therapeutics Development Initiative

The Michael J. Fox Foundation for Parkinson’s Research: Therapeutics Development Initiative

Presentation, June 2008. More >>>>>

Post navigation

TorreyPines Therapeutics Licenses Posiphen®, Bisnorcymcerine and Phenserine to QR Pharma

Search for:

Recent Posts

Targeting Alzheimer’s and Other Neurodegenerative Diseases via a Novel Mechanism of Action
Targeting Alzheimer’s with Novel Therapuetics
Healthcare Businesswomen’s Association: Women in Science – Winter 2011
Maria Maccecchini to Receive 2011 Iris Newmann Award – November 16, 2011
Maria Maccecchini, President and CEO of QR Pharma, Inc. to Serve on Panel with Nobel Laureate, Phillip Sharp at Chemical Heritage Foundation Event

QR Pharma, Inc. © All rights reserved

ABOUT US
PRIVACY POLICY
TERMS OF USE
SITE MAP
CONTACT

Scroll to Top